لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المساهمون: Buzdar, Aman U.

مصطلحات موضوعية: Breast -- Cancer -- Hormone therapy., Breast -- Cancer -- Endocrine aspects., Breast Neoplasms -- drug therapy., Antineoplastic Agents, Hormonal -- therapeutic use.

المؤلفون: Plätzer, Eva

مصطلحات موضوعية: ddc:610, Mammakarzinom, adjuvante endokrine Therapie, Tamoxifen, Tamoxifenresistenz, Aromataseinhibitor, GPR30, GPER 1, Immunhistochemie Östrogenrezeptor Adult, Aged, Antineoplastic Agents, Hormonal / therapeutic use, Breast Neoplasms / drug therapy, Breast Neoplasms / metabolism, Breast Neoplasms / pathology, Carcinoma, Ductal, Breast / drug therapy, Carcinoma, Ductal, Breast / metabolism, Carcinoma, Ductal, Breast / pathology, Carcinoma, Lobular / drug therapy, Carcinoma, Lobular / metabolism, Carcinoma, Lobular / pathology, Disease Progression, Drug Resistance, Neoplasm, Female, Follow-Up Studies, Humans, Immunoenzyme Techniques, Middle Aged, Neoplasm Recurrence, Local / drug therapy, Neoplasm Recurrence, Local / metabolism, Neoplasm, Recurrence, Local / pathology, Neoplasm Staging, Receptors, Estrogen, Receptors, G-Protein-Coupled / metabolism, Retrospective Studies, Survival Rate, Tamoxifen / therapeutic use, Treatment Outcome, 610 Medizin

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1224c80690dd2d0c1e3de6670ef481f2
https://epub.uni-regensburg.de/53163/

المؤلفون: Rosie Bradley, Jeremy Braybrooke, Richard Gray, Robert K Hills, Zulian Liu, Hongchao Pan, Richard Peto, David Dodwell, Paul McGale, Carolyn Taylor, Prudence A Francis, Michael Gnant, Francesco Perrone, Meredith M Regan, Richard Berry, Clare Boddington, Mike Clarke, Christina Davies, Lucy Davies, Fran Duane, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Raimund Jakesz, Christian Fesl, Olivia Pagani, Richard Gelber, Michelino De Laurentiis, Sabino De Placido, Ciro Gallo, Kathy Albain, Stewart Anderson, Rodrigo Arriagada, John Bartlett, Elizabeth Bergsten-Nordström, Judith Bliss, Etienne Brain, Lisa Carey, Robert Coleman, Jack Cuzick, Nancy Davidson, Lucia Del Mastro, Angelo Di Leo, James Dignam, Mitch Dowsett, Bent Ejlertsen, Matthew Goetz, Pam Goodwin, Pat Halpin-Murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori Pierce, Philip Poortmans, Kathleen I Pritchard, Vinod Raina, Daniel Rea, John Robertson, Emiel Rutgers, Tanja Spanic, Joseph Sparano, Guenther Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Tim Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Sandra M Swain

المساهمون: Bradley, R., Braybrooke, J., Gray, R., Hills, R. K., Liu, Z., Pan, H., Peto, R., Dodwell, D., Mcgale, P., Taylor, C., Francis, P. A., Gnant, M., Perrone, F., Regan, M. M., Berry, R., Boddington, C., Clarke, M., Davies, C., Davies, L., Duane, F., Evans, V., Gay, J., Gettins, L., Godwin, J., James, S., Liu, H., Mackinnon, E., Mannu, G., Mchugh, T., Morris, P., Read, S., Straiton, E., Jakesz, R., Fesl, C., Pagani, O., Gelber, R., De Laurentiis, M., De Placido, S., Gallo, C., Albain, K., Anderson, S., Arriagada, R., Bartlett, J., Bergsten-Nordstrom, E., Bliss, J., Brain, E., Carey, L., Coleman, R., Cuzick, J., Davidson, N., Del Mastro, L., Di Leo, A., Dignam, J., Dowsett, M., Ejlertsen, B., Goetz, M., Goodwin, P., Halpin-Murphy, P., Hayes, D., Hill, C., Jagsi, R., Janni, W., Loibl, S., Mamounas, E. P., Martin, M., Mukai, H., Nekljudova, V., Norton, L., Ohashi, Y., Pierce, L., Poortmans, P., Pritchard, K. I., Raina, V., Rea, D., Robertson, J., Rutgers, E., Spanic, T., Sparano, J., Steger, G., Tang, G., Toi, M., Tutt, A., Viale, G., Wang, X., Whelan, T., Wilcken, N., Wolmark, N., Cameron, D., Bergh, J., Swain, S. M., Bradbury, R, Braybrooke, J, Gray, R, Hills, R, Liu, Z, Pan, H, Peto, R, Dodwell, D, McGale, P

المصدر: Bradley, R, Braybrooke, J, Gray, R, Hills, R K, Liu, Z, Pan, H, Peto, R, Dodwell, D, McGale, P, Taylor, C, Francis, P A, Gnant, M, Perrone, F, Regan, M M, Berry, R, Boddington, C, Clarke, M, Davies, C, Davies, L, Duane, F, Evans, V, Gay, J, Gettins, L, Godwin, J, James, S, Liu, H, MacKinnon, E, Mannu, G, McHugh, T, Morris, P, Read, S, Straiton, E, Jakesz, R, Fesl, C, Pagani, O, Gelber, R, De Laurentiis, M, De Placido, S, Gallo, C, Albain, K, Anderson, S, Arriagada, R, Bartlett, J, Bergsten-Nordström, E, Bliss, J, Brain, E, Carey, L, Coleman, R, Cuzick, J, Ejlertsen, B & Early Breast Cancer Trialists' Collaborative Group (EBCTCG) 2022, ' Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression : a patient-level meta-analysis of 7030 women from four randomised trials ', The Lancet Oncology, vol. 23, no. 3, pp. 382-392 . https://doi.org/10.1016/S1470-2045(21)00758-0
Bradley, R, Braybrooke, J, Gray, R, Hills, R K, Liu, Z, Pan, H, Peto, R, Dodwell, D, Mcgale, P, Taylor, C, Francis, P A, Gnant, M, Perrone, F, Regan, M M, Berry, R, Boddington, C, Clarke, M, Davies, C, Davies, L, Duane, F, Evans, V, Gay, J, Gettins, L, Godwin, J, James, S, Liu, H, Mackinnon, E, Mannu, G, Mchugh, T, Morris, P, Read, S, Straiton, E, Jakesz, R, Fesl, C, Pagani, O, Gelber, R, De Laurentiis, M, De Placido, S, Gallo, C, Albain, K, Anderson, S, Arriagada, R, Bartlett, J, Bergsten-nordström, E, Bliss, J, Brain, E, Carey, L, Coleman, R, Cuzick, J, Davidson, N, Del Mastro, L, Di Leo, A, Dignam, J, Dowsett, M, Ejlertsen, B, Goetz, M, Goodwin, P, Halpin-murphy, P, Hayes, D, Hill, C, Jagsi, R, Janni, W, Loibl, S, Mamounas, E P, Martín, M, Mukai, H, Nekljudova, V, Norton, L, Ohashi, Y, Pierce, L, Poortmans, P, Pritchard, K I, Raina, V, Rea, D, Robertson, J, Rutgers, E, Spanic, T, Sparano, J, Steger, G, Tang, G, Toi, M, Tutt, A, Viale, G, Wang, X, Whelan, T, Wilcken, N, Wolmark, N, Cameron, D, Bergh, J & Swain, S M 2022, ' Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials ', The Lancet Oncology, vol. 23, no. 3, pp. 382-392 . https://doi.org/10.1016/S1470-2045(21)00758-0

مصطلحات موضوعية: Breast Neoplasms/pathology, Antineoplastic Agents, Hormonal/therapeutic use, Antineoplastic Agents, Hormonal, Aromatase Inhibitors, Breast Neoplasms, Tamoxifen, Neoplasm Recurrence, Local/drug therapy, Tamoxifen/therapeutic use, Oncology, Receptors, Estrogen, Chemotherapy, Adjuvant, Humans, Aromatase Inhibitor, Female, Aromatase Inhibitors/adverse effects, Neoplasm Recurrence, Local, Human, Randomized Controlled Trials as Topic

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::099cd29eddf49f551ce58241f52c0672
https://curis.ku.dk/portal/da/publications/aromatase-inhibitors-versus-tamoxifen-in-premenopausal-women-with-oestrogen-receptorpositive-earlystage-breast-cancer-treated-with-ovarian-suppression(f389c226-4a8e-4bac-aa3d-555d87bfdfab).html

المؤلفون: Hilborn, Erik

المساهمون: Linköpings universitet. Institutionen för klinisk och experimentell medicin

مصطلحات موضوعية: SNP, droplet digital PCR, HSD17B1, HSD17B2, miRNA, Breast Neoplasms -- metabolism, Chemokine CXCL10 -- metabolism, Receptors, CXCR3 -- metabolism, Antineoplastic Agents, Hormonal -- therapeutic use, Neoplasm Recurrence, Local, Estrogen Receptor alpha -- metabolism, Receptor, ErbB-2 -- metabolism, Receptors, Androgen -- metabolism, Receptors, Progesterone -- metabolism, Tamoxifen -- therapeutic use

URL الوصول: http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-132453

Degree: Diss. (sammanfattning) Linköping : Linköpings universitet, 2016

المؤلفون: Pascal Blanchet, Thierry Lebret, Matthias E Meunier, Laurent Brureau, Yann Neuzillet

المساهمون: Hôpital Foch [Suresnes], Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), CHU Pointe-à-Pitre/Abymes [Guadeloupe], HAL UR1, Admin, Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )

المصدر: BMC Cancer
BMC Cancer, BioMed Central, 2021, 21 (1), pp.61. ⟨10.1186/s12885-020-07780-7⟩
BMC Cancer, 2021, 21 (1), pp.61. ⟨10.1186/s12885-020-07780-7⟩
BMC Cancer, Vol 21, Iss 1, Pp 1-5 (2021)

مصطلحات موضوعية: Male, Oncology, Cancer Research, [SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology, MESH: African Americans / statistics & numerical data, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Surgical oncology, Apalutamide, 030212 general & internal medicine, Prospective cohort study, Abiraterone, Prostate Cancer, Prognosis, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 3. Good health, Survival Rate, 030220 oncology & carcinogenesis, [SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, MESH: Survival rate, Research Article, medicine.medical_specialty, Antineoplastic Agents, Hormonal, MESH: Prostatic Neoplasmes / drug therapy, [SDV.CAN]Life Sciences [q-bio]/Cancer, Hormonotherapy, lcsh:RC254-282, MESH: Prognosis, 03 medical and health sciences, [SDV.CAN] Life Sciences [q-bio]/Cancer, Internal medicine, Genetics, medicine, Enzalutamide, Humans, MESH: Antineoplastic Agents, Hormonal / therapeutic use, Black men, MESH: Humans, business.industry, Prostatic Neoplasms, medicine.disease, [SDV.MHEP.UN] Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology, MESH: Male, Black or African American, Androgen receptor, chemistry, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, business, MESH: Postatic Neoplasmes / pathology, Hormone

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af869ac28de170ffd2fa2c172805141b
https://hal.archives-ouvertes.fr/hal-03134963/file/s12885-020-07780-7

المؤلفون: Hasni, Muhammad Sharif

مصطلحات موضوعية: Estrogen Receptor, beta -- agonists, Estrogen Receptor, beta -- therapeutic use, Lymphoma, Non-Hodgkin -- therapy, Antineoplastic Agents, Hormonal -- therapeutic use, Neoplasms, Experimental, Sex Factors

Degree: Diss. (sammanfattning) Stockholm : Karolinska Institutet, 2015

المؤلفون: M. P. Van Den Berg, Sophie E. Aapkes, Ron T. Gansevoort, Joost P.H. Drenth, Lucas H P Bernts

المساهمون: Groningen Kidney Center (GKC), Cardiovascular Centre (CVC)

المصدر: Medicine (Baltimore), 100
Medicine (Baltimore), 100, 32
Medicine, 100(32):e26797. LIPPINCOTT WILLIAMS & WILKINS

مصطلحات موضوعية: medicine.medical_specialty, Liver Diseases/diagnosis, Antineoplastic Agents, Hormonal/therapeutic use, medicine.drug_class, medicine.medical_treatment, Antineoplastic Agents, Cysts/diagnosis, Liver transplantation, Gastroenterology, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], Breast cancer, All institutes and research themes of the Radboud University Medical Center, Internal medicine, Medicine, Humans, Cyst, Hormonal/therapeutic use, Tomography, business.industry, Polycystic liver disease, General Medicine, Middle Aged, medicine.disease, X-Ray Computed, Renal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11], Tamoxifen/therapeutic use, Estrogen, Female, Liver function, business, Tomography, X-Ray Computed, Tamoxifen, medicine.drug, Rare disease, Follow-Up Studies

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0473ff3364f93b102c841b5fc4590c79
https://doi.org/10.1097/md.0000000000026797

المؤلفون: Chavez Sanchez, Betzabé

مصطلحات موضوعية: Tamoxifen -- therapeutic use, Antineoplastic Agents, Hormonal -- therapeutic use, Breast Neoplasms -- drug therapy, Drug Resistance, Neoplasm, Individualized Medicine, Vascular Endothelial Growth Factors -- metabolism

URL الوصول: http://hdl.handle.net/10616/40687

Degree: Diss. (sammanfattning) Stockholm : Karolinska institutet, 2011

المؤلفون: Sautois, Brieuc, GENNIGENS, Christine

المصدر: Revue Médicale de Liège, 68 (2), 94-6 (2013)

مصطلحات موضوعية: Androstenols/administration & dosage, Antineoplastic Agents, Hormonal/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Clinical Trials, Phase III as Topic, Disease Progression, Disease-Free Survival, Drug Resistance, Neoplasm, Humans, Male, Multicenter Studies as Topic, Orchiectomy, Phenylthiohydantoin/administration & dosage/analogs & derivatives, Prostatic Neoplasms/drug therapy/mortality/pathology/surgery, Randomized Controlled Trials as Topic, Taxoids/administration & dosage, Treatment Outcome, Human health sciences, Oncology, Sciences de la santé humaine, Oncologie

Relation: urn:issn:0370-629X; urn:issn:2566-1566

URL الوصول: https://orbi.uliege.be/handle/2268/155599